Viperin is an IFN-stimulated gene (ISG)-encoded protein that was identified in human primary macrophages treated with IFN-γ and in human primary fibroblasts infected with cytomegalovirus (CMV). This protein plays multiple roles in various cell types. It inhibits viral replication, mediates signaling pathways, and regulates cellular metabolism. Recent studies have shown that viperin inhibits IFN expression in macrophages, while it enhances TLR7 and TLR9-mediated IFN production in plasmacytoid dendritic cells, suggesting that viperin can play different roles in activation of the same pathway in different cell types. Viperin also controls induction of ISGs in macrophages. However, the effect of viperin on induction of ISGs in cell types other than macrophages is unknown. Here, we show that viperin differentially induces ISGs in 2 distinct cell types, macrophages and fibroblasts isolated from wild type and viperin knockout mice. Unlike in bone marrow-derived macrophages (BMDMs), viperin downregulates the expression levels of ISGs such as bone marrow stromal cell antigen-2, Isg15, Isg54, myxovirus resistance dynamin like GTPase 2, and guanylate binding protein 2 in murine embryonic fibroblasts (MEFs) treated with type I or II IFN. However, viperin upregulates expression of these ISGs in both BMDMs and MEFs stimulated with polyinosinic-polycytidylic acid or CpG DNA and infected with murine CMV. The efficiency of viral entry is inversely proportional to the expression levels of ISGs in both cell types. The data indicate that viperin differentially regulates induction of ISGs in a cell type-dependent manner, which might provide different innate immune responses in distinct cell types against infections.
INTRODUCTION
The IFN response is the first line of host defense against diverse pathogens. Patternrecognition receptors such as TLRs and RIG-I-like receptors recognize infectious agents and activate transcription factors, IFN-regulatory factors (IRFs) and NF-κB (1) . The transcription factors subsequently mediate production of IFNs and pro-inflammatory cytokines. The secreted IFNs trigger induction of a large number of IFN-stimulated genes (ISGs) including 2′5′-oligoadenylate synthetase (Oas), ribonuclease L, IFN-inducible dsRNA-dependent protein Macrophages are innate immune cells that have functions in phagocytosis, antigen presentation, and immunomodulation (4) . They can be polarized into 2 different subsets, classically activated macrophages (M1) and alternatively activated macrophages (M2) (5) . M1 macrophages produce pro-inflammatory cytokines and provide a host defense against pathogens (6, 7) . M2 macrophages secrete anti-inflammatory cytokines and have repairing function (6, 7) . It has been reported that IFN responses affect the inflammatory functions of macrophages (8, 9) . Some ISG products expressed in macrophages promote inflammation and others inhibit (10) (11) (12) (13) (14) .
Fibroblasts are ubiquitous mesenchymal cells that play roles in wound healing, antigen presentation, and maintenance of homeostasis (15) (16) (17) . They are also important for immune responses. Fibroblasts can initiate inflammation in the presence of invading pathogens. They produce many different cytokines including IFNs and modulate extracellular matrix components against infectious pathogens (15) (16) (17) . The ISG products expressed in fibroblasts exert their diverse antipathogenic properties (18) (19) (20) .
Viperin (virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) was first identified in human primary macrophages stimulated with IFN-γ and in human fibroblasts infected with human cytomegalovirus (CMV) (21, 22) . It is also induced in a variety of cells by treatment of type I, II, and III IFNs, ds B-form DNA, the dsRNA analog polyinosinic-polycytidylic acid (poly[I:C]), or LPS and infection of a wide range of viruses (23) . Viperin protein has multiple functions in various cell types including macrophages, fibroblasts, dendritic cells, adipocytes, and astrocytes (24) (25) (26) (27) (28) (29) (30) . This protein exhibits antiviral activity against many viruses (25) (26) (27) (28) , mediates signaling pathways or T cell development (29, 31) , and modulates cellular metabolism (24, 30, 32) . It also plays a pivotal role in activation of macrophages, dendritic cells, and T cells (31, (33) (34) (35) . Recent studies have shown that viperin is a positive regulator of TLR7-and TLR9-mediated production of type I IFNs in plasmacytoid dendritic cells (pDCs) (29), while this protein is a negative regulator of mitochondrial antiviral signaling protein (MAVS)-linked IFN-β induction in macrophages (36) . It suggests that viperin differentially regulates IFN induction in different cell types. Viperin also upregulates expression of most ISGs in macrophages in the absence or presence of type I IFN (36) . Despite the importance of ISG products in innate immunity, the effect of viperin on induction of ISGs in cell types other than macrophages has not been examined.
In this study, we show that viperin differentially regulates ISG induction in two distinct cell types, macrophages and fibroblasts treated with type I or II IFNs. Viperin upregulates ISG expression in bone marrow-derived macrophages (BMDMs) treated with IFNs, while it downregulates ISG expression in murine embryonic fibroblasts (MEFs). Interestingly, viperin upregulates ISG expression in both BMDMs and MEFs stimulated with poly(I:C), CpG DNA, or CMV other than IFNs. The efficiency of viral entry depends on the levels of ISG expression in both cell types treated with CMV in the absence or presence of IFNs. Our data indicate that viperin differentially regulates ISG induction in a cell type-dependent manner under IFNs treatments, and in a stimulus-dependent manner through an IFN signaling pathway. It suggests that viperin-mediated differential expression of ISGs might provide different innate immune responses in distinct cell types against diverse pathogens.
MATERIALS AND METHODS

Cells, viruses, antibodies, and reagents
Murine bone marrow cells and MEFs used in the study were isolated from wild type (WT) or viperin (Rsad2) knockout (KO) C57BL/6 mice (24, 34) . MEFs were immortalized by serial passages as described previously (24) .
The Smith strain of murine cytomegalovirus (MCMV) and monoclonal antibody Croma 101 (anti-immediate early 1 [IE1]) were kindly provided by Dr. W.J. Britt (University of Alabama at Birmingham). Viperin was detected with the monoclonal mouse antibody to viperin (MaP. VIP) described previously (21, 27) . The monoclonal mouse anti-ISG15 antibody (Santa Cruz Biotechnology, Inc., Dallas, TX, USA), monoclonal rat anti-GRP94 antibody (Enzo Life Sciences, Inc., Farmingdale, NY, USA), and horseradish peroxidase-conjugated goat antimouse or anti-rat IgG antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) were used. Universal type I IFN (PBL Assay Science, Piscataway, NJ, USA), recombinant mouse IFN-γ (R&D systems, Minneapolis, MN, USA), poly(I:C) (InvivoGen, San Diego, CA, USA), CpG DNA (Enzo Life Sciences, Inc.), and Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA, USA) were also used.
Mouse M-CSF was stably expressed in CHO cells and the culture supernatants containing the secreted M-CSF were used for generation of BMDMs as described previously (37) . 
Generation of BMDMs
Stimulation of BMDMs and MEFs
BMDMs and MEFs were treated with 1000 U/ml IFN-I (PBL Assay Science) or 100 ng/ml IFN-γ (R&D systems) for 24 h. The cells were transfected with 1 μg/ml poly(I:C) (InvivoGen) or 1 μg/ml CpG DNA (Enzo Life Sciences, Inc.) using Lipofectamine 2000 (Thermo Fisher Scientific). The cells were infected with MCMV at the initial multiplicity of infection (MOI) of 0.2 or 2 in the absence or presence of IFNs, and incubated for 24 h.
Immunoblot analysis
Cells were harvested and lysed in lysis buffer (1% Triton X-100 in TRIS-buffered saline) containing proteinase inhibitors. Supernatants of lysates were collected, and the concentration of proteins was measured by bicinchoninic acid (BCA) assay (Thermo Fisher Scientific). The proteins were separated on 15% SDS-PAGE gels and transferred to polyvinylidene fluoride membranes (Millipore, Burlington, MA, USA). The blots were blocked with 5% skim milk and 0.05% Tween in PBS for 1 h, incubated with primary antibodies for 1 day, probed with horseradish peroxidase-conjugated secondary antibodies for 1 h, followed by incubation with enhanced chemiluminescence reagents (Thermo Fisher Scientific). The intensity of bands was analyzed using ImageJ software.
Immunofluorescence
Cells were grown in 24-well cell culture plates containing a 13-mm-diameter coverslip. The coverslips were harvested by washing cells with PBS and then fixing cells with 3% paraformaldehyde in PBS for 45 min at room temperature. The coverslips were washed with PBS and permeabilized with 0.1% Triton X-100 and 0.01% SDS in PBS for 7 min. The coverslips were then blocked with 0.2% Tween in PBS containing 10% normal goat serum (Thermo Fisher Scientific) for 20 min at room temperature, followed by the addition of the monoclonal mouse antibody Croma 101 (anti-IE1), and incubated for 1 h at room temperature. The coverslips were washed with 0.2% Tween in PBS and incubated with anti-mouse Ig secondary antibody conjugated to dye (Thermo Fisher Scientific) for 45 min at room temperature. The coverslips were washed with 0.2% Tween in PBS, rinsed once in PBS, and mounted with ProLong Gold Antifade reagent (Molecular Probes, Eugene, OR, USA). The images were acquired with a Zeiss LSM700 scanning laser confocal microscope (Carl Zeiss AG, Oberkochen, Germany) and analyzed using Zeiss ZEN 2012 software and ImageJ software.
RNA extraction, cDNA preparation, and quantitative real-time PCR
Cells were collected and total RNA were extracted using RNeasy Mini kit (Qiagen, Hilden, Germany). The cDNA was synthesized with 1 μg RNA using Prime script RT reagent kit according to the manufacturer's instructions (Takara Bio, Kusatsu, Japan). The cDNA obtained from cells was quantified by quantitative real-time PCR (qRT-PCR) using TB Green Fast qPCR reagent kit (Takara Bio). The sequences of primers for the PCR are listed in Supplementary Table 1 . The reaction included 95°C for 5 min, which was followed by a 3-step PCR program of 95°C for 30 s, 60°C for 5 s, and 72°C for 15 s repeated for 40 cycles. The PCR was performed in triplicate for each sample. The quantitation of the results was performed by the comparative Ct (2 −ΔΔCt ) method. The Ct value for each sample was normalized by the value for β-actin gene. Three independent experiments were analyzed statistically for differences in the mean values, and p values are indicated in the figures.
Statistical analysis
The data are presented as mean±SEM. Statistical significance was determined with unpaired 2-tailed Student's t-test using GraphPad Prism 5 software. The p values less than 0.05 were considered significant.
RESULTS
Viperin differentially regulates expression of ISGs in 2 different cell types treated with IFNs
Viperin enhances ISG expression in macrophages in the absence or presence of type I IFN (36), but its effect on cell types other than macrophages has not been examined. We therefore investigated the role of viperin in ISG induction in 2 distinct cell types, macrophages and fibroblasts. Bone marrow cells were isolated from WT and viperin KO mice and differentiated into BMDMs in M-CSF conditioned media. MEFs were also isolated from these mice and immortalized as described previously (24) . The expression levels of ISGs, Viperin, bone marrow stromal cell antigen-2 (Bst-2), Isg15, Isg54, myxovirus resistance dynamin like GTPase 2 (Mx2), guanylate binding protein 2 (Gbp2), and Isg56 that are known to be highly increased in cells upon IFN stimulation (36, (38) (39) (40) (41) , were measured in WT and viperin KO BMDMs or MEFs (Fig. 1) . Consistent with previous studies (36) , the increases in expression levels of these ISGs were greater in WT BMDMs compared with viperin KO BMDMs treated with type I IFN ( Fig. 1A and Supplementary Fig. 1 ). The expression level of ISG15 protein in WT BMDMs was also higher than that of ISG15 in viperin KO BMDMs treated with type I IFN (Fig. 1B) . Viperin was basally expressed in WT BMDMs and highly increased upon type I IFN stimulation (Fig. 1B) (34) . In contrast, the increases in expression levels of these ISGs, except for Isg56, were less in WT MEFs compared with viperin KO MEFs treated with type I IFN ( Fig. 1C and Supplementary Fig. 1 ). The expression level of ISG15 in WT MEFs was also lower than that of ISG15 in viperin KO MEFs treated with type I IFN (Fig. 1D) . Viperin was not basally expressed in MEFs, but it was highly induced in WT MEFs treated with type I IFN (Fig. 1D) (Fig. 2) . Similar to the results from type I IFN treatment, viperin differently affects ISG expression in BMDMs and MEFs treated with IFN-γ (Fig. 2) . The results suggested that viperin is a cell typespecific regulator of ISG expression in type I or II IFN-mediated signaling pathway. (Fig. 3) . The increases in expression levels of these ISGs were significantly greater in WT BMDMs compared with viperin KO BMDMs treated with poly(I:C) or CpG DNA (Fig. 3A) .
Viperin enhances expression of ISGs in cells treated with poly(I:C) or CpG DNA
The expression level of ISG15 in WT BMDMs was also higher than that of ISG15 in viperin KO BMDMs treated with poly(I:C) or CpG DNA ( Fig. 3B and C) . Like in BMDMs, viperin enhances ISG expression in MEFs treated with poly(I:C) or CpG DNA (Fig. 3D-F) . The results suggested that viperin plays a role as a positive regulator on expression of ISGs in response to certain stimuli which mediate IFN production.
Viperin differentially regulates expression of ISGs in different cell types upon viral infection and/or IFN treatment
To examine the effects of viperin on ISG expression in cells infected with virus, the expression levels of ISGs, Viperin, Bst-2, Oas1, Isg15, Isg54, Isg56, Mx2, and Gbp2 were measured in WT and viperin KO BMDMs or MEFs infected with MCMV in the absence or presence of type I IFN (Fig. 4) . The increases in expression levels of these ISGs were greater in WT BMDMs compared with viperin KO BMDMs infected with MCMV both in the absence and presence of type I IFN (Fig. 4A) . While the increases in expression levels of these ISGs were greater in WT MEFs compared with viperin KO MEFs infected with MCMV in the absence of type I IFN, those of these ISGs except for Isg56 were less in WT MEFs compared with viperin KO MEFs infected with MCMV in the presence of type I IFN (Fig. 4B) . Similar results were obtained from BMDMs and MEFs infected with MCMV in the absence or presence of IFN-γ ( Fig. 5A and B) . The data indicated that like in CpG DNA treatment, viperin enhances ISG expression of both BMDMs and MEFs after DNA virus infection. However, the effects of viperin on ISG expression by viral infection in MEFs were overwhelmed by IFN treatment, resulting in that viperin differentially regulates ISG expression in these 2 cell types. 
MCMV entry depends on viperin-mediated ISG expression
To determine whether viperin-mediated ISG expression affects viral infection, the efficiency of MCMV entry into WT and viperin KO BMDMs or MEFs were measured (Fig. 6) . WT and viperin KO BMDMs were infected with MCMV for 24 h in the absence or presence of type I or II IFN (Fig. 6A and B) . Cells expressing an MCMV protein, IE1 protein, were monitored (Fig. 6A) . The efficiency of viral entry was quantitated by the percentage of cells expressing IE1 protein (Fig. 6B) . infection (Supplementary Fig. 2 ). While the number of IE1-positive cells was less in WT MEFs compared with viperin KO MEFs infected with MCMV in the absence of IFNs, that was greater in WT MEFs compared with viperin KO MEFs infected with MCMV in the presence of IFNs (Fig. 6C and D) . The results indicated that the efficiency of viral entry is inversely proportional to the expression levels of ISGs mediated by viperin in both cell types.
DISCUSSION
ISG products play critical roles in innate immunity against infectious pathogens (1, 3) . ISGs are induced by various stimuli including pathogens and IFNs. It suggested that ISG expression can be regulated by two distinct signaling pathways, the signaling pathways to induce IFN production and the JAK/STAT pathway to induce IFN-mediated ISG expression (1, 3) . Viperin is a highly induced ISG protein in many cell types including macrophages and fibroblasts (23 The Effects of Viperin on Induction of ISGs increases expression of ISGs in BMDMs treated with IFN-γ. IL-1β limits production of type I IFN through direct transcriptional downregulation and prostaglandin-endoperoxide synthase 2-dependent prostaglandin E2 production. Inversely, type I IFN modulates the inflammatory microenvironment and suppresses production of cytokines (8, 9, 46) . The balance of immune responses is important to prevent tissue damage and autoimmunity (9, 46) . Therefore, our data suggested that viperin may be involved in maintenance of a balance between ISGs and cytokines in inflammatory responses of macrophages.
The efficiency of MCMV entry was dependent on viperin-mediated ISG expression levels in cells infected with MCMV in the absence or presence of IFNs. The viral entry was less in both WT BMDMs and MEFs compared with viperin KO cells after MCMV infection. However, in the presence of IFNs, unlike in BMDMs, the viral entry was greater in WT MEFs compared with viperin KO MEFs after MCMV infection. Our data indicated that the efficiency of viral entry is inversely proportional to the expression levels of ISGs shown in both cell types. Our data also suggested that although viperin increases viral replication by modulating cellular metabolism in the late stage of human cytomegalovirus infection (24, 32) , the expression levels of ISGs mediated by viperin may determine viral infectivity in the early stage of CMV infection. Alternatively, the efficiency of MCMV entry in cells infected with MCMV in the presence of IFNs may be affected by viperin itself. Upon a combined treatment of CMV and IFN, viperin is highly induced and its antiviral or proviral activity may differently acts on BMDMs and MEFs.
In conclusion, we demonstrated that viperin differentially regulates expression of ISGs in distinct cell types. The data suggested that viperin is a key regulator in production of inflammatory molecules such as IFNs, ISGs, and cytokines in innate immune responses, and its regulation mechanism is dependent on cell type or stimulus. Our findings may provide a clue to develop new strategies of IFN therapy in immune-mediated or infection-associated diseases. 
